Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:1600  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 

    Article Cited by others

REVIEW ARTICLE

Tuberculosis: Current situation, challenges and overview of its control programs in India

Sandhu Gursimrat K

Year : 2011| Volume: 3| Issue : 2 | Page no: 143-150

   This article has been cited by
 
1 Analysis of CD4 and CD8 expression in multidrug-resistant tuberculosis infection with diabetes mellitus: An experimental study in mice
Heidy Agustin, Muhammad Nasrum Massi, Irawati Djaharuddin, Agus Dwi Susanto, Andi Asadul Islam, Mochammad Hatta, Agussalim Bukhari, Nur Ahmad Tabri, Arif Santoso, Ilhamjaya Patellongi
Annals of Medicine and Surgery. 2021; 68: 102596
[Pubmed]  [Google Scholar] [DOI]
2 Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discovery
Mayuri S. Prasad, Ritesh P. Bhole, Pramod B. Khedekar, Rupesh V. Chikhale
Bioorganic Chemistry. 2021; 115: 105242
[Pubmed]  [Google Scholar] [DOI]
3 Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis
Satyaveni Malasala, Md Naiyaz Ahmad, Ravikumar Akunuri, Manjulika Shukla, Grace Kaul, Arunava Dasgupta, Y.V. Madhavi, Sidharth Chopra, Srinivas Nanduri
European Journal of Medicinal Chemistry. 2021; 212: 112996
[Pubmed]  [Google Scholar] [DOI]
4 Status and challenges for tuberculosis control in India – Stakeholders' perspective
Gargi Thakur, Shalvi Thakur, Harshad Thakur
Indian Journal of Tuberculosis. 2021; 68(3): 334
[Pubmed]  [Google Scholar] [DOI]
5 Identification of bioactive natural compounds as efficient inhibitors against Mycobacterium tuberculosis protein-targets: A molecular docking and molecular dynamics simulation study
Sravan Kumar Miryala, Soumya Basu, Aniket Naha, Reetika Debroy, Sudha Ramaiah, Anand Anbarasu, Saravanan Natarajan
Journal of Molecular Liquids. 2021; 341: 117340
[Pubmed]  [Google Scholar] [DOI]
6 Tuberculous ARDS is associated with worse outcome when compared with non-tuberculous infectious ARDS
Thomas Isaiah Sudarsan, Lovely Thomas, Abhishek Samprathi, Binila Chacko, Alice Mathuram, Tina George, Gunasekaran Karthik, Sudha Jasmine Rajan, Ronald Albert Benton Carey, Gowri Mahasampath, John Victor Peter
Journal of Critical Care. 2021; 61: 138
[Pubmed]  [Google Scholar] [DOI]
7 State Feedback and Synergetic controllers for tuberculosis in infected population
Muhammad Bilal, Iftikhar Ahmad, Sheraz Ahmad Babar, Khurram Shahzad
IET Systems Biology. 2021; 15(3): 83
[Pubmed]  [Google Scholar] [DOI]
8 Computational exploration and anti-mycobacterial activity of potential inhibitors of Mycobacterium tuberculosis acetyl coenzyme A carboxylase as anti-tubercular agents
J. Kuldeep, S.K. Sharma, B.N. Singh, M.I. Siddiqi
SAR and QSAR in Environmental Research. 2021; 32(3): 191
[Pubmed]  [Google Scholar] [DOI]
9 Is Mycobacterium tuberculosis carcinogenic to humans?
Deodutta Roy, Nasreen Z. Ehtesham, Seyed Ehtesham Hasnain
The FASEB Journal. 2021; 35(9)
[Pubmed]  [Google Scholar] [DOI]
10 Mitigating the externality of diseases of poverty through health aid
Kamal Jnawali, Michael G. Tyshenko, Tamer Oraby
Royal Society Open Science. 2021; 8(10)
[Pubmed]  [Google Scholar] [DOI]
11 Modeling and analysis of barriers in controlling TB: developing countries' perspective
Palka Mittal, Puneeta Ajmera, Vineet Jain, Gaurav Aggarwal
International Journal of Health Governance. 2021; ahead-of-p(ahead-of-p)
[Pubmed]  [Google Scholar] [DOI]
12 Long-term exposure to indoor air pollution and risk of tuberculosis
Vidhiben Patel, Andrew Foster, Alison Salem, Amit Kumar, Vineet Kumar, Biplab Biswas, Mehdi Mirsaeidi, Naresh Kumar
Indoor Air. 2021; 31(3): 628
[Pubmed]  [Google Scholar] [DOI]
13 Tuberculosis amidst COVID-19 pandemic in India: unspoken challenges and the way forward
Mainak Bardhan, Mohammad Mehedi Hasan, Ishita Ray, Anusua Sarkar, Priyanka Chahal, Sudhan Rackimuthu, Mohammad Yasir Essar
Tropical Medicine and Health. 2021; 49(1)
[Pubmed]  [Google Scholar] [DOI]
14 Hybrid PET/MRI findings in a case of pulmonary and extra-pulmonary tuberculosis associated with motor-neuron disease-like illness—a coincidence or a causation?: a case report
Sameer Peer, Chandana Nagaraj, Sandhya Mangalore
Egyptian Journal of Radiology and Nuclear Medicine. 2021; 52(1)
[Pubmed]  [Google Scholar] [DOI]
15 A Rare Case of Tuberculosis Cutis Colliquative
Shravya Rimmalapudi, Amruta D. Morey, Bhushan Madke, Adarsh Lata Singh, Sugat Jawade
Journal of Evolution of Medical and Dental Sciences. 2021; 10(5): 305
[Pubmed]  [Google Scholar] [DOI]
16 “TUBERCULOSIS – A COMMON GRANULOMATOUS DISEASE AT UNCOMMON SITES: A COMPREHENSIVE HISTOCYTOLOGICAL STUDY IN A TERTIARY CARE HOSPITAL OF CENTRAL INDIA”
Anki Saluja, Rashmi Gupta, Chitrangi P. Barpande, B. P. Singh
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. 2021; : 65
[Pubmed]  [Google Scholar] [DOI]
17 ISONIAZID MONORESISTANCE : THE NEW CHALLENGE IN DRUG RESISTANT TUBERCULOSIS
Paulami Palchowdhury, Anindita Rakshit, Aitihya Chakraborty, Banya Chakraborty
INDIAN JOURNAL OF APPLIED RESEARCH. 2021; : 38
[Pubmed]  [Google Scholar] [DOI]
18 Need-based training of community health officers for tuberculosis care in Ahmednagar district of Maharashtra, India: A before and after study
MandarPadmakar Baviskar, Ankita Sinha, ShubhadaS Javadekar, Rajvir Bhalwar
Journal of Education and Health Promotion. 2021; 10(1): 322
[Pubmed]  [Google Scholar] [DOI]
19 Contribution of community pharmacy in treating tuberculosis: A pharmacy centric study from Belagavi district
UdayKumar Rangaswamy, MadiwalayyaS Ganachari
Journal of Reports in Pharmaceutical Sciences. 2020; 9(2): 246
[Pubmed]  [Google Scholar] [DOI]
20 Bedaquiline: A Mini Review
Nandhini Saravanabavan, Padmavathi Shanmuganathan, Manimekalai Kumarappan
Annals of SBV. 2020; 8(1): 2
[Pubmed]  [Google Scholar] [DOI]
21 TO SEE THE IMPACT OF LOCKDOWN IN COVID19 PANDEMIC ON TUBERCULAR PATIENTS IN A TERTIARY CARE CENTRE OF HILLY AREA.
Subhash Chander, Ritin Sharma, Ankit Chaudhary, Rakesh Chauhan
INDIAN JOURNAL OF APPLIED RESEARCH. 2020; : 33
[Pubmed]  [Google Scholar] [DOI]
22 Tendência e caracterização epidemiológica da tuberculose em Alagoas, 2007-2016
Clodis Maria Tavares, Amanda Maria Silva da Cunha, Nataly Mayara Cavalcante Gomes, Ana Beatriz de Almeida Lima, Igor Michel Ramos dos Santos, Mileyse da Silva Acácio, Daniella Marques dos Santos, Carlos Dornels Freire de Souza
Cadernos Saúde Coletiva. 2020; 28(1): 107
[Pubmed]  [Google Scholar] [DOI]
23

Factors Affecting Tuberculosis Patients’ Quality of Life in Surabaya, Indonesia

Ni Njoman Juliasih, Ni Made Mertaniasih, Cholichul Hadi, . Soedarsono, Reny Mareta Sari, Ilham Nur Alfian
Journal of Multidisciplinary Healthcare. 2020; Volume 13: 1475
[Pubmed]  [Google Scholar] [DOI]
24 The Biotin Biosynthetic Pathway in Mycobacterium tuberculosis is a Validated Target for the Development of Antibacterial Agents
Matthew R. Bockman, Neeraj Mishra, Courtney C. Aldrich
Current Medicinal Chemistry. 2020; 27(25): 4194
[Pubmed]  [Google Scholar] [DOI]
25 Piperonal: The Journey so Far
Jain Akash, Chaudhary Dushyant, Chaudhary Jasmine
Mini-Reviews in Medicinal Chemistry. 2020; 20(18): 1846
[Pubmed]  [Google Scholar] [DOI]
26 Microscopic Observation Drug Susceptibility (MODS) Assay: A Convenient Method for Determining Antibiogram of Clinical Isolates of Mycobacterium tuberculosis in Ghana
Enid Owusu, Mercy Jemima Newman
Medical Sciences. 2020; 8(1): 5
[Pubmed]  [Google Scholar] [DOI]
27 Altered systemic levels of acute phase proteins in tuberculous lymphadenitis and modulation after treatment
Gokul Raj Kathamuthu, Kadar Moideen, Nathella Pavan Kumar, Rathinam Sridhar, Dhanaraj Baskaran, Subash Babu, Martin E. Rottenberg
PLOS ONE. 2020; 15(5): e0233426
[Pubmed]  [Google Scholar] [DOI]
28 Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia
Melaku Tilahun, Ezra Shimelis, Teklu Wogayehu, Gebeyehu Assefa, Getachew Wondimagegn, Alemayehu Mekonnen, Tsegaye Hailu, Kidist Bobosha, Abraham Aseffa, Hasnain Seyed Ehtesham
PLOS ONE. 2020; 15(8): e0236054
[Pubmed]  [Google Scholar] [DOI]
29 Squamous Cell Carcinoma in the Post Tuberculosis Lung after 30 Years of Treatment Completion
Arulprashanth Arulanantham, Umesh Jayarajah, Rohitha Dharmasiri, Rasarathinam Jeyanthakumar, Kamila Niroshan Siriwardena, Sujeewa Ilangamge
Case Reports in Surgery. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
30 Isoniazid–phytochemical conjugation: A new approach for potent and less toxic anti-TB drug development
Shasank S. Swain, Sudhir K. Paidesetty, Rabindra N. Padhy, Tahziba Hussain
Chemical Biology & Drug Design. 2020; 96(2): 714
[Pubmed]  [Google Scholar] [DOI]
31 Ethnobotanical study of selected medicinal plants traditionally used in the rural Greater Mpigi region of Uganda
Fabien Schultz, Godwin Anywar, Barbara Wack, Cassandra Leah Quave, Leif-Alexander Garbe
Journal of Ethnopharmacology. 2020; 256: 112742
[Pubmed]  [Google Scholar] [DOI]
32 Synthesis, biological evaluation and molecular modelling insights of 2-arylquinazoline benzamide derivatives as anti-tubercular agents
Satyaveni Malasala, Md Naiyaz Ahmad, Jitendra Gour, Manjulika Shukla, Grace Kaul, Abdul Akhir, Srikanth Gatadi, Y.V. Madhavi, Sidharth Chopra, Srinivas Nanduri
Journal of Molecular Structure. 2020; 1218: 128493
[Pubmed]  [Google Scholar] [DOI]
33 Current status of point-of-care diagnostic devices in the Indian healthcare system with an update on COVID-19 pandemic
Aditya Narayan Konwar, Vivek Borse
Sensors International. 2020; 1: 100015
[Pubmed]  [Google Scholar] [DOI]
34 Copper mediated one-pot synthesis of quinazolinones and exploration of piperazine linked quinazoline derivatives as anti-mycobacterial agents
Satyaveni Malasala, Jitendra Gour, Md. Naiyaz Ahmad, Srikanth Gatadi, Manjulika Shukla, Grace Kaul, Arunava Dasgupta, Y. V. Madhavi, Sidharth Chopra, Srinivas Nanduri
RSC Advances. 2020; 10(71): 43533
[Pubmed]  [Google Scholar] [DOI]
35 Paradigm shift in efforts to end TB by 2025
K.S. Sachdeva, Malik Parmar, Raghuram Rao, Sandeep Chauhan, Vaibhav Shah, Ra Pirabu, Deepak Balasubramaniam, Bhavin Vadera, S. Anand, Manu Mathew, Hardik Solanki, V.V. Sundar
Indian Journal of Tuberculosis. 2020; 67(4): S48
[Pubmed]  [Google Scholar] [DOI]
36 Design, synthesis, and characterization of novel substituted 1,2,4-oxadiazole and their biological broadcast
Paranjay H. Parikh, Jignesh B. Timaniya, Mrugesh J. Patel, Kaushal P. Patel
Medicinal Chemistry Research. 2020; 29(3): 538
[Pubmed]  [Google Scholar] [DOI]
37 The Role of Biotin in Bacterial Physiology and Virulence: a Novel Antibiotic Target for Mycobacterium tuberculosis
Wanisa Salaemae, Grant W. Booker, Steven W. Polyak, Indira T. Kudva, Bryan H. Bellaire
Microbiology Spectrum. 2016; 4(2)
[Pubmed]  [Google Scholar] [DOI]
38 Doctorsæ compliance with national guidelines and clinical pathway on the treatment of tuberculosis inpatients in Hubei, China
Xiaofei Zheng,Fangying Zhong,Xinping Zhang
Journal of Evaluation in Clinical Practice. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
39 Risk Factors of Tuberculosis Infection Among HIV/AIDS Patients in Burkina Faso
Ziemlé Clément Méda,Issiaka Sombié,Olivier W.C. Sanon,Daouda Maré,Donald E. Morisky,Yi-Ming Arthur Chen
AIDS Research and Human Retroviruses. 2013; 29(7): 1045
[Pubmed]  [Google Scholar] [DOI]
40 Pharmacovigilance and Public Health Ethics
Torbjörn Callréus
Pharmaceutical Medicine. 2013; 27(3): 157
[Pubmed]  [Google Scholar] [DOI]
41 Burgeoning double burden of tuberculosis and diabetes in India: Magnitude of the problem – Strategies and solutions
Preety Sharma,Fehmida Visnegarwala,Vinay Tripathi
Clinical Epidemiology and Global Health. 2013;
[Pubmed]  [Google Scholar] [DOI]
42 Risk factors of tuberculosis infection among HIV/AIDS patients in Burkina Faso
Méda, Z.C. and Sombié, I. and Sanon, O.W.C. and Maré, D. and Morisky, D.E. and Chen, Y.-M.A.
AIDS Research and Human Retroviruses. 2013; 29(7): 1045-1055
[Pubmed]  [Google Scholar]
43 Pharmacovigilance and public health ethics
Callréus, T.
Pharmaceutical Medicine. 2013; 27(3): 157-164
[Pubmed]  [Google Scholar]
44 Effect of Piper nigrum on in-vitro release of isoniazid from oral microspheres
Pingale, P. and Ravindra, R.P.
International Journal of Pharma and Bio Sciences. 2013; 4(1): 1027-1036
[Pubmed]  [Google Scholar]
45 Molecular Epidemiology of Mycobacteriosis in Wildlife and Pet Animals
Schrenzel, M.D.
Veterinary Clinics of North America - Exotic Animal Practice. 2012; 15(1): 1-23
[Pubmed]  [Google Scholar]
46 Dermatomyositis and chest radiography leading to the diagnosis of lung cancer and subsequent confusions in staging due to the presence of tuberculosis
Revannasiddaiah, S. and Gupta, M.K. and Rastogi, M. and Kesari, A.A.R. and Seam, R.K. and Gupta, M. and Chauhan, S. and Madabhavi, I.
BMJ Case Reports. 2012;
[Pubmed]  [Google Scholar]
47 Molecular Epidemiology of Mycobacteriosis in Wildlife and Pet Animals
Mark D. Schrenzel
Veterinary Clinics of North America: Exotic Animal Practice. 2012; 15(1): 1
[Pubmed]  [Google Scholar] [DOI]
48 Gene dose effect of NAT2 variants on the pharmacokinetics of isoniazid and acetylisoniazid in healthy Chinese subjects
Chen, B. and Cao, X. and Li, J.
Drug Metabolism and Drug Interactions. 2011; 26(3): 113-118
[Pubmed]  [Google Scholar]
49 Gene dose effect of NAT2 variants on the pharmacokinetics of isoniazid and acetylisoniazid in healthy Chinese subjects
Chen Bing,Cao Xiaomeia,Li Jinhenga
Drug Metabolism and Drug Interactions. 2011; 26(3)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008